Monte Rosa Therapeutics Vs. Fabrinet Industry Stock Comparison

Buy

60

GLUE
Monte Rosa Therapeutics

Last Price:

$6.29

Seasonality Move:

-16.98%

Buy

74

FN
Fabrinet

Last Price:

$220.16

Seasonality Move:

2.27%

Buy

60

Monte Rosa Therapeutics (GLUE) is a Buy

Is Monte Rosa Therapeutics a Buy, Sell or Hold?

The current Monte Rosa Therapeutics [GLUE] share price is $6.21. The Score for GLUE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
GLUE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

74

Fabrinet (FN) is a Buy

Is Fabrinet a Buy, Sell or Hold?

The current Fabrinet [FN] share price is $223.66. The Score for FN is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
FN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GLUE Stock Price Chart

What is Monte Rosa Therapeutics's stock price today?

The Monte Rosa Therapeutics share price today is $6.21

The current trend is relatively stagnant and GLUE is experiencing selling pressure, which indicates risk of future bearish movement.

FN Stock Price Chart

What is Fabrinet's stock price today?

The Fabrinet share price today is $223.66

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FN is experiencing slight buying pressure.

GLUE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.05	Sell
Relative Strength Index (14 RSI):	50.13	Buy
Chaikin Money Flow:	-285490	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(5.86 - 6.72)	Sell
Bollinger Bands (100):	(5.67 - 8.63)	Sell

FN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-5.43	Sell
Relative Strength Index (14 RSI):	56.36	Buy
Chaikin Money Flow:	370714	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(195.23 - 224.51)	Buy
Bollinger Bands (100):	(211.34 - 249.88)	Sell

GLUE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	6.14	Buy
20-day SMA:	6.18	Buy
50-day SMA:	6.26	Sell
200-day SMA:	5.95	Buy
8-day EMA:	6.21	Buy
20-day EMA:	6.19	Buy
50-day EMA:	6.42	Sell
200-day EMA:	6.33	Sell

FN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	197.43	Buy
20-day SMA:	209.1	Buy
50-day SMA:	219.48	Buy
200-day SMA:	232.93	Sell
8-day EMA:	203.8	Buy
20-day EMA:	207.34	Buy
50-day EMA:	216.8	Buy
200-day EMA:	221.88	Buy

Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.24 per share.

Fabrinet Earnings Growth & FN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.02 per share, an increase this year of $1.57 per share, and an increase next year of $1.32 per share.

Monte Rosa Therapeutics Technical Analysis

	Feb 27	Feb 28	Mar 3	Mar 4	Mar 5	Mar 6	Mar 7	Mar 11	Mar 12	Mar 13
	Feb			Mar
	27	28	03	04	05	06	07	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Fabrinet Technical Analysis

	Feb 27	Feb 28	Mar 3	Mar 4	Mar 5	Mar 6	Mar 7	Mar 11	Mar 12	Mar 13
	Feb			Mar
	27	28	03	04	05	06	07	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):